Urachal cancer is a rare type of bladder cancer--there have only been around 350 cases ever reported and it only accounts for less than 1% of all bladder cancers. The urachal ligament is a structure that connects the bellybutton to the top of the bladder. Most individuals lose this connection after birth but some people maintain this structure throughout their lifetimes. This is the area where the tumor arises, most always an adenocarcinoma. Because there are so few cases of urachal cancer, its cause is unknown but a genetic as well as an environmental component is believed to be playing a critical role. Individuals with urachal cancer have a good survival rate if detected early, however approximately 50% of those diagnosed will pass away due to their disease. Because in many cases the cancer has not spread and is localized, many treatments for urachal cancer include surgery, radiations, and chemotherapy, however these treatments are all considered experimental at this time.
Urachal Cancer Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Urachal Cancer below!
For more information on how to use Laverne, please read the How to Guide.
We have 1844 products for the study of Urachal Cancer that can be applied to Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry, Chromatin Immunoprecipitation (ChIP) from our catalog of antibodies and ELISA kits.